These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9007096)

  • 1. Low brain GABA level is associated with poor seizure control.
    Petroff OA; Rothman DL; Behar KL; Mattson RH
    Ann Neurol; 1996 Dec; 40(6):908-11. PubMed ID: 9007096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vigabatrin increases human brain homocarnosine and improves seizure control.
    Petroff OA; Mattson RH; Behar KL; Hyder F; Rothman DL
    Ann Neurol; 1998 Dec; 44(6):948-52. PubMed ID: 9851440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy.
    Petroff OA; Rothman DL; Behar KL; Lamoureux D; Mattson RH
    Ann Neurol; 1996 Jan; 39(1):95-9. PubMed ID: 8572673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain homocarnosine and seizure control of patients taking gabapentin or topiramate.
    Petroff OA; Hyder F; Rothman DL; Mattson RH
    Epilepsia; 2006 Mar; 47(3):495-8. PubMed ID: 16529611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy.
    Petroff OA; Hyder F; Mattson RH; Rothman DL
    Neurology; 1999 Feb; 52(3):473-8. PubMed ID: 10025774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures.
    Petroff OA; Rothman DL; Behar KL; Hyder F; Mattson RH
    Seizure; 1999 Apr; 8(2):120-7. PubMed ID: 10222306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human brain gamma-aminobutyric acid levels and seizure control following initiation of vigabatrin therapy.
    Petroff OA; Behar KL; Mattson RH; Rothman DL
    J Neurochem; 1996 Dec; 67(6):2399-404. PubMed ID: 8931472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
    Rothman DL; Petroff OA; Behar KL; Mattson RH
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5662-6. PubMed ID: 8516315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy.
    Petroff OA; Rothman DL; Behar KL; Collins TL; Mattson RH
    Neurology; 1996 Dec; 47(6):1567-71. PubMed ID: 8960747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid gamma-aminobutyric acid and glutamate values in dogs with epilepsy.
    Podell M; Hadjiconstantinou M
    Am J Vet Res; 1997 May; 58(5):451-6. PubMed ID: 9140549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders.
    Chang L; Cloak CC; Ernst T
    J Clin Psychiatry; 2003; 64 Suppl 3():7-14. PubMed ID: 12662128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics.
    Mueller SG; Weber OM; Duc CO; Weber B; Meier D; Russ W; Boesiger P; Wieser HG
    Epilepsia; 2001 Jan; 42(1):29-40. PubMed ID: 11207782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New NMR measurements in epilepsy. Measuring brain GABA in patients with complex partial seizures.
    Petroff OA; Behar KL; Rothman DL
    Adv Neurol; 1999; 79():939-45. PubMed ID: 10514877
    [No Abstract]   [Full Text] [Related]  

  • 14. Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.
    Petroff OA; Rothman DL
    Mol Neurobiol; 1998 Feb; 16(1):97-121. PubMed ID: 9554704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.
    Hasler G; van der Veen JW; Tumonis T; Meyers N; Shen J; Drevets WC
    Arch Gen Psychiatry; 2007 Feb; 64(2):193-200. PubMed ID: 17283286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study.
    Ke Y; Streeter CC; Nassar LE; Sarid-Segal O; Hennen J; Yurgelun-Todd DA; Awad LA; Rendall MJ; Gruber SA; Nason A; Mudrick MJ; Blank SR; Meyer AA; Knapp C; Ciraulo DA; Renshaw PF
    Psychiatry Res; 2004 Apr; 130(3):283-93. PubMed ID: 15135161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High gamma-aminobutyric acid level in cortical tubers in epileptic infants with tuberous sclerosis complex measured with the MEGA-editing J-difference method and a three-Tesla clinical MRI Instrument.
    Taki MM; Harada M; Mori K; Kubo H; Nose A; Matsuda T; Nishitani H
    Neuroimage; 2009 Oct; 47(4):1207-14. PubMed ID: 19481612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy.
    Hasler G; Neumeister A; van der Veen JW; Tumonis T; Bain EE; Shen J; Drevets WC; Charney DS
    Biol Psychiatry; 2005 Dec; 58(12):969-73. PubMed ID: 16043137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA receptors, lipids, and gangliosides in cobalt epileptic focus.
    Craig CR; Colasanti BK
    Adv Neurol; 1986; 44():379-91. PubMed ID: 3010678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal lobectomy: long-term seizure outcome, late recurrence and risks for seizure recurrence.
    McIntosh AM; Kalnins RM; Mitchell LA; Fabinyi GC; Briellmann RS; Berkovic SF
    Brain; 2004 Sep; 127(Pt 9):2018-30. PubMed ID: 15215219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.